STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER

To date, the role of human papillomavirus (HpV) in the development of lung cancer is still under investigation. The available published data do not provide evidence of the involvement of HpV in lung cancer pathogenesis. In Russia, there are no reports regarding the studies of viral contribution to l...

Full description

Saved in:
Bibliographic Details
Main Authors: M. K. Ibragimova, M. M. Tsyganov, A. M. Pevzner, E. O. Rodionov, O. V. Cheremisina, S. V. Miller, S. A. Tuzikov, N. V. Litviakov
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2021-05-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/1755
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849253191760216064
author M. K. Ibragimova
M. M. Tsyganov
A. M. Pevzner
E. O. Rodionov
O. V. Cheremisina
S. V. Miller
S. A. Tuzikov
N. V. Litviakov
author_facet M. K. Ibragimova
M. M. Tsyganov
A. M. Pevzner
E. O. Rodionov
O. V. Cheremisina
S. V. Miller
S. A. Tuzikov
N. V. Litviakov
author_sort M. K. Ibragimova
collection DOAJ
description To date, the role of human papillomavirus (HpV) in the development of lung cancer is still under investigation. The available published data do not provide evidence of the involvement of HpV in lung cancer pathogenesis. In Russia, there are no reports regarding the studies of viral contribution to lung carcinogenesis.The aim of the present study was to examine the presence of high-risk HpV infection in patients with non-small cell lung cancer (NSCLC).Material and Methods. The study included 30 patients with histologically verified stage IIBIIIA NSCLC. Normal and tumor lung tissue samples as well as whole blood samples from each patient were used. dNA was isolated from tissue samples using the QIAamp dNA mini Kit (Qiagen, Germany). Amplisens® reagent kits (Moscow, Russia) were used for dNA isolation and genotyping.Results. The presence of HpV dNA was detected in 3 (10.0 %) patients. HpV dNA was not detected in 27 (90.0 %) patients. HpV-16 genotype was observed in 2 HpV-positive patients, and HpV-33 was observed in 1 patient. A clinically insignificant viral load was found in almost all HpV-positive samples. The assessment of the virus integration in HpV16-positive lung cancer patients revealed mixed and integrated forms of the virus in the tumor tissue of these patients. The 5-year metastasis-free survival rate in all HpV-positive patients was 100 %.Conclusion. Our data showed HpV dNA prevalence rate of 10 % among NSCLC patients in the Russian population. The presence/absence of a viral component for lung cancer patients is a clinically significant parameter.
format Article
id doaj-art-bd7d6198040e4188a5efcd7ef05f4cfe
institution Kabale University
issn 1814-4861
2312-3168
language Russian
publishDate 2021-05-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj-art-bd7d6198040e4188a5efcd7ef05f4cfe2025-08-20T03:56:24ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682021-05-01202536010.21294/1814-4861-2021-20-2-53-60844STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCERM. K. Ibragimova0M. M. Tsyganov1A. M. Pevzner2E. O. Rodionov3O. V. Cheremisina4S. V. Miller5S. A. Tuzikov6N. V. Litviakov7Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk State UniversityCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk State UniversityCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State University, Ministry of Healthcare of the Russian FederationCancer Research Institute, Tomsk National Research Medical Center, Russian Academy of SciencesTo date, the role of human papillomavirus (HpV) in the development of lung cancer is still under investigation. The available published data do not provide evidence of the involvement of HpV in lung cancer pathogenesis. In Russia, there are no reports regarding the studies of viral contribution to lung carcinogenesis.The aim of the present study was to examine the presence of high-risk HpV infection in patients with non-small cell lung cancer (NSCLC).Material and Methods. The study included 30 patients with histologically verified stage IIBIIIA NSCLC. Normal and tumor lung tissue samples as well as whole blood samples from each patient were used. dNA was isolated from tissue samples using the QIAamp dNA mini Kit (Qiagen, Germany). Amplisens® reagent kits (Moscow, Russia) were used for dNA isolation and genotyping.Results. The presence of HpV dNA was detected in 3 (10.0 %) patients. HpV dNA was not detected in 27 (90.0 %) patients. HpV-16 genotype was observed in 2 HpV-positive patients, and HpV-33 was observed in 1 patient. A clinically insignificant viral load was found in almost all HpV-positive samples. The assessment of the virus integration in HpV16-positive lung cancer patients revealed mixed and integrated forms of the virus in the tumor tissue of these patients. The 5-year metastasis-free survival rate in all HpV-positive patients was 100 %.Conclusion. Our data showed HpV dNA prevalence rate of 10 % among NSCLC patients in the Russian population. The presence/absence of a viral component for lung cancer patients is a clinically significant parameter.https://www.siboncoj.ru/jour/article/view/1755hpvlung cancerprognosisphysical status of the viruslung cancer pathogenesis
spellingShingle M. K. Ibragimova
M. M. Tsyganov
A. M. Pevzner
E. O. Rodionov
O. V. Cheremisina
S. V. Miller
S. A. Tuzikov
N. V. Litviakov
STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER
Сибирский онкологический журнал
hpv
lung cancer
prognosis
physical status of the virus
lung cancer pathogenesis
title STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER
title_full STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER
title_fullStr STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER
title_full_unstemmed STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER
title_short STUDY OF THE HUMAN PAPILLOMA VIRUS PREVALENCE AND ITS PHYSICAL STATUS IN PATIENS WITH NON-SMALL CELL LUNG CANCER
title_sort study of the human papilloma virus prevalence and its physical status in patiens with non small cell lung cancer
topic hpv
lung cancer
prognosis
physical status of the virus
lung cancer pathogenesis
url https://www.siboncoj.ru/jour/article/view/1755
work_keys_str_mv AT mkibragimova studyofthehumanpapillomavirusprevalenceanditsphysicalstatusinpatienswithnonsmallcelllungcancer
AT mmtsyganov studyofthehumanpapillomavirusprevalenceanditsphysicalstatusinpatienswithnonsmallcelllungcancer
AT ampevzner studyofthehumanpapillomavirusprevalenceanditsphysicalstatusinpatienswithnonsmallcelllungcancer
AT eorodionov studyofthehumanpapillomavirusprevalenceanditsphysicalstatusinpatienswithnonsmallcelllungcancer
AT ovcheremisina studyofthehumanpapillomavirusprevalenceanditsphysicalstatusinpatienswithnonsmallcelllungcancer
AT svmiller studyofthehumanpapillomavirusprevalenceanditsphysicalstatusinpatienswithnonsmallcelllungcancer
AT satuzikov studyofthehumanpapillomavirusprevalenceanditsphysicalstatusinpatienswithnonsmallcelllungcancer
AT nvlitviakov studyofthehumanpapillomavirusprevalenceanditsphysicalstatusinpatienswithnonsmallcelllungcancer